On December 20, 2024, multiple directors and executives of GSK plc made significant share purchases. Lady Susan Symonds, PCA of Non-Executive Chair Sir Jonathan Symonds, acquired 1,500 Ordinary Shares at £13.1508 each on the London Stock Exchange. Wendy Becker purchased 546 Ordinary Shares at £13.1900 per share.Several Independent Non-Executive Directors, including Elizabeth McKee Anderson, Charles Bancroft, Dr. Hal Barron, Dr. Anne Beal, Dr. Hal Dietz, Dr. Jesse Goodman, Dr. Jeannie Lee, and Dr. Vishal Sikka, bought American Depositary Shares (ADSs) at $33.8097 each on the New York Stock Exchange. Notably, Charles Bancroft, the Senior Independent Non-Executive Director, acquired 2,184 ADSs, while Dr. Vishal Sikka purchased 937 ADSs.These transactions demonstrate a strong vote of confidence in GSK's future prospects by its leadership team, potentially signaling positive expectations for the company's performance and strategy.

On December 20, 2024, multiple directors and executives of GSK plc made significant share purchases. Lady Susan Symonds, PCA of Non-Executive Chair Sir Jonathan Symonds, acquired 1,500 Ordinary Shares at £13.1508 each on the London Stock Exchange. Wendy Becker purchased 546 Ordinary Shares at £13.1900 per share.Several Independent Non-Executive Directors, including Elizabeth McKee Anderson, Charles Bancroft, Dr. Hal Barron, Dr. Anne Beal, Dr. Hal Dietz, Dr. Jesse Goodman, Dr. Jeannie Lee, and Dr. Vishal Sikka, bought American Depositary Shares (ADSs) at $33.8097 each on the New York Stock Exchange. Notably, Charles Bancroft, the Senior Independent Non-Executive Director, acquired 2,184 ADSs, while Dr. Vishal Sikka purchased 937 ADSs.These transactions demonstrate a strong vote of confidence in GSK's future prospects by its leadership team, potentially signaling positive expectations for the company's performance and strategy.